<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>14</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Let-7c Inhibits NSCLC Cell Proliferation by Targeting HOXA1</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>387</FirstPage>
			<LastPage>392</LastPage>
			<ELocationID EIdType="pii">27336</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;br/&gt;&lt;b&gt;Objective&lt;/b&gt;: The aim of the present study was to explore mechanisms by which let-7c suppresses NSCLC cellproliferation. &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: The expression level of let-7c was quantified by qRT-PCR. A549 and H1299 cells weretransfected with let-7c mimics to restore the expression of let-7c. The effects of let-7c were then assessed by cellproliferation, colony formation and cell cycle assay. Mouse experiments were used to confirm the effect of let-7con tumorigenicity in vivo. Luciferase reporter assays and Western blotting were performed to identify targetgenes for let-7c. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: HOXA1 was identified as a novel target of let-7c. MTS, colony formation and flowcytometry assays demonstrated that forced expression of let-7c inhibited NSCLC cell proliferation by inducingG1 arrest in vitro, consistent with inhibitory effects induced by knockdown of HOXA1. Mouse experimentsdemonstrated that let-7c expression suppressed tumorigenesis. Furthermore, we found that let-7c could regulatethe expression of HOXA1 downstream effectors CCND1, CDC25A and CDK2. &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: Collectively, theseresults demonstrate let-7c inhibits NSCLC cell proliferation and tumorigenesis by partial direct targeting ofthe HOXA1 pathway, which suggests that restoration of let-7c expression may thus offer a potential therapeuticintervention strategy for NSCLC.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Let-7c</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">NSCLC</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">HOXA1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">G1 arrest</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_27336_9b8e5279f2ca3fcdb18c34a313340678.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
